QQQSInvesco NASDAQ Future Gen 200 ETF
Tracks the Nasdaq Innovators Completion Cap™ Index.
By Invesco · Launched 2022
Annual Cost
0.20%
#934 of 5,854 · low cost
Fund Size
$21M
#4,417 of 5,854 · small
Return (1Y)Goal
+53.7%
Track Record
3 years
#2,752 of 5,854 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$15,568+55.7%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Small
Strategy
Index tracking
Index tracked
Nasdaq Innovators Completion Cap Index
What it actually holds
By weightConcentration
Top 10 holdings = 39.5% of fund✓ well diversified
Invesco Private Prime Fund
22.8%
Invesco Private Government Fund
8.8%
AXT, Inc.
1.7%
Innovative Solutions and Support, Inc.
1.3%
Allogene Therapeutics, Inc.
0.9%
Neogen Corp.
0.9%
Shattuck Labs, Inc.
0.9%
Alector, Inc.
0.9%
Entegris, Inc.
0.8%
Vanda Pharmaceuticals Inc.
0.8%
Asset allocation
Stocks
100.0%
By sector
Healthcare
57.1%
Technology
26.0%
Industrials
6.0%
Consumer Cyclical
5.7%
Communication
2.9%
Consumer Defensive
1.4%
Basic Materials
0.5%
Energy
0.4%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
27.3%High
Year-on-year price swings
Max drawdown
-38.1%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.50Decent risk-adjusted returns
Sortino (3Y)
0.73Moderate downside risk
Listing
- Exchange
- NASDAQ Global Select Market
Full fund details
- Objective
- Tracks the Nasdaq Innovators Completion Cap™ Index.
- Strategy
- Invests at least 90% of total assets in securities of approximately 200 Nasdaq-listed non-financial companies outside of the Nasdaq-100 Index, selected based on the value of their patent portfolios. Employs full replication methodology to track the Underlying Index, which is equally weighted and includes companies of any capitalization, with significant exposure to health care and information technology sectors.
- Inception date
- October 13, 2022
- Fund family
- Invesco
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at QQQS. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-03